{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:15:27Z","timestamp":1794734127520,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019717","name":"AstraZeneca Pharmaceutical Spain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.diabres.2025.112326","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:39:22Z","timestamp":1750333162000},"page":"112326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Screening, prevalence, and burden of chronic kidney disease in people with type 2 diabetes managed by endocrinologists: A nationwide cross-sectional study"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9761-6888","authenticated-orcid":false,"given":"Jos\u00e9 Ignacio","family":"Mart\u00ednez-Montoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1755-5518","authenticated-orcid":false,"given":"Jose Juan","family":"Aparicio-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-9231","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1648-6609","authenticated-orcid":false,"given":"M\u00f3nica","family":"Ju\u00e1rez-Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7724-3144","authenticated-orcid":false,"given":"Mar\u00eda Luisa","family":"Alamillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2229-8488","authenticated-orcid":false,"given":"Jos\u00e9 Carlos","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112326_b0005","unstructured":"IDF Diabetes Atlas [Internet]. Brussels, Belgium; 2021 [cited 2025 Jun 21]. Available from: https:\/\/www.diabetesatlas.org."},{"issue":"11","key":"10.1016\/j.diabres.2025.112326_b0010","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/jcm8111795","article-title":"Chronic kidney disease: the silent epidemy","volume":"8","author":"Bellasi","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.diabres.2025.112326_b0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trendsof chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.diabres.2025.112326_b0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in prevalence of chronic kidney disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2025.112326_b0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12882-018-0942-1","article-title":"Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus","volume":"19","author":"Go","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.diabres.2025.112326_b0030","unstructured":"IDF Diabetes Atlas Report, Diabetes and kidney disease 2024. 2024."},{"issue":"6","key":"10.1016\/j.diabres.2025.112326_b0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014","volume":"316","author":"Afkarian","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2025.112326_b0040","unstructured":"United States Renal Data System. 2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, Maryland; 2023."},{"issue":"8","key":"10.1016\/j.diabres.2025.112326_b0045","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/dom.14401","article-title":"Prevalence and progression of chronic kidney disease among patients with type 2diabetes: insights from the DISCOVER study","volume":"23","author":"Khunti","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112326_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12916-022-02234-2","article-title":"Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"issue":"13","key":"10.1016\/j.diabres.2025.112326_b0055","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.diabres.2025.112326_b0060","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.diabres.2025.112326_b0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/diacare.27.3.699","article-title":"Heart failure prevalence, incidence, and mortality in the elderly with diabetes","volume":"27","author":"Bertoni","year":"2004","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2025.112326_b0070","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/dom.14074","article-title":"Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study","volume":"22","author":"Birkeland","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"10.1016\/j.diabres.2025.112326_b0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","article-title":"CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease","volume":"14","author":"Anders","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.diabres.2025.112326_b0080","first-page":"509","article-title":"Epidemiology and resource use in spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary","volume":"69","author":"Sicras-Mainar","year":"2022","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed)"},{"issue":"8","key":"10.1016\/j.diabres.2025.112326_b0085","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40273-015-0268-9","article-title":"The economic costs of type 2 diabetes: a global systematic review","volume":"33","author":"Seuring","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.diabres.2025.112326_b0090","doi-asserted-by":"crossref","unstructured":"Kerr M, Bray B, Medcalf J, O\u2019Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrology Dialysis Transplantation. 2012 Oct;27(suppl_3):iii73\u201380.","DOI":"10.1093\/ndt\/gfs269"},{"issue":"9854","key":"10.1016\/j.diabres.2025.112326_b0095","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.diabres.2025.112326_b0100","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.kint.2016.12.013","article-title":"A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population","volume":"91","author":"Garofalo","year":"2017","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.diabres.2025.112326_b0105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","article-title":"Obesity, kidney dysfunction and hypertension: mechanistic links","volume":"15","author":"Hall","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.diabres.2025.112326_b0110","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","article-title":"Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.diabres.2025.112326_b0115","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the american diabetes association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112326_b0120","unstructured":"Telotron \u2013 Telomera. [Internet]. HMA-EMA Catalogues of real-world data sources and studies . 2024 [cited 2024 Dec 23]. Available from: https:\/\/catalogues.ema.europa.eu\/node\/1078\/administrative-details."},{"key":"10.1016\/j.diabres.2025.112326_b0125","unstructured":"Ley Org\u00e1nica 3\/2018, de 5 de diciembre, de Protecci\u00f3n de Datos Personales y garant\u00eda de los derechos digitales. Bolet\u00edn Oficial del Estado, 3\/2018 Spain: https:\/\/www.boe.es; Dec 5, 2018."},{"issue":"12","key":"10.1016\/j.diabres.2025.112326_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2024.10.3583","article-title":"External validity and representativeness of TELOTRON\u00ae database: a reliable source for real-world evidence research in Spain","volume":"27","author":"Alamillo","year":"2024","journal-title":"Value Health"},{"issue":"19","key":"10.1016\/j.diabres.2025.112326_b0135","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2025.112326_b0140","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.diabres.2025.112326_b0145","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.0000222373.59104.3d","article-title":"Recommendations for evaluating Compliance and persistence with hypertension therapy using retrospective data","volume":"47","author":"Halpern","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.diabres.2025.112326_b0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMe1906559","article-title":"New guidelines for statistical reporting in the journal","volume":"381","author":"Harrington","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2025.112326_b0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2025.112326_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-14-46","article-title":"Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study","author":"Rodriguez-Poncelas","year":"2013","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112326_b0165","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.pcd.2021.02.003","article-title":"Evaluation of clinical and antidiabetic treatment characteristics of different sub-groups of patients with type 2 diabetes: Data from a Mediterranean population database","volume":"15","author":"Mata-Cases","year":"2021","journal-title":"Prim Care Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2025.112326_b0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nefro.2017.11.025","article-title":"Enfermedad renal cr\u00f3nica en Espa\u00f1a: prevalencia y factores relacionados en personas con diabetes mellitus mayores de 64 a\u00f1os","volume":"38","author":"Mart\u00ednez Candela","year":"2018","journal-title":"Nefrolog\u00eda"},{"issue":"3","key":"10.1016\/j.diabres.2025.112326_b0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065927","article-title":"Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink","volume":"13","author":"Cook","year":"2023","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.diabres.2025.112326_b0180","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.clinthera.2021.07.015","article-title":"Prevalence of chronic kidney disease in type 2 diabetes: the Canadian REgistry of chronic kidney disease in diabetes outcomes (CREDO) study","volume":"43","author":"Chu","year":"2021","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.diabres.2025.112326_b0185","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/ckj\/sfac100","article-title":"The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis","volume":"15","author":"Marques","year":"2022","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.diabres.2025.112326_b0190","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12325-023-02482-5","article-title":"Patient management and clinical outcomes associated with a recorded diagnosis of stage 3 chronic kidney disease: the REVEAL-CKD study","volume":"40","author":"Tangri","year":"2023","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.diabres.2025.112326_b0195","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064513","article-title":"Association between practice coding of chronic kidney disease (CKD) in primary care and subsequent hospitalisations and death: a cohort analysis using national audit data","volume":"12","author":"Cleary","year":"2022","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.diabres.2025.112326_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110535","article-title":"Primary Care Detection of Chronic Kidney Disease in adults with Type-2 Diabetes: the ADD-CKD Study (Awareness, Detection and Drug Therapy in Type 2 Diabetes and Chronic Kidney Disease)","volume":"9","author":"Szczech","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.diabres.2025.112326_b0205","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2337\/dc20-2715","article-title":"Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 U.S. health care organizations","volume":"44","author":"Stempniewicz","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2025.112326_b0210","first-page":"302","article-title":"Underdiagnosis identification of chronic kidney disease in primary care","volume":"22","author":"Serrano","year":"2019","journal-title":"Enfermeria Nefrologica"},{"issue":"1","key":"10.1016\/j.diabres.2025.112326_b0215","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1080\/13696998.2023.2235922","article-title":"Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes","volume":"26","author":"Rossing","year":"2023","journal-title":"J Med Econ"},{"issue":"3","key":"10.1016\/j.diabres.2025.112326_b0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ki.2013.181","article-title":"LDL cholesterol in CKD\u2014to treat or not to treat?","volume":"84","author":"Massy","year":"2013","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.diabres.2025.112326_b0225","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ejhf.778","article-title":"The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction","volume":"19","author":"Nayor","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.diabres.2025.112326_b0230","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003825","article-title":"Heart failure increases the risk of adverse Renal Outcomes in patients with Normal Kidney Function","volume":"10","author":"George","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.diabres.2025.112326_b0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12902-022-01026-2","article-title":"Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes","volume":"22","author":"Arnold","year":"2022","journal-title":"Results from DISCOVER BMC Endocr Disord"},{"issue":"2","key":"10.1016\/j.diabres.2025.112326_b0240","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc21-1815","article-title":"Utilization rates of SGLT2 Inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the department of veterans affairs","volume":"45","author":"Mahtta","year":"2022","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725003407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725003407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:45:36Z","timestamp":1762260336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725003407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"alternative-id":["S0168822725003407"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112326","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening, prevalence, and burden of chronic kidney disease in people with type 2 diabetes managed by endocrinologists: A nationwide cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112326"}}